H.M. Sampoerna Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? H.M. Sampoerna Tbk. trades at Rp695 (market cap 79.68T, 7.53M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: H.M. Sampoerna Tbk. is far larger — about 476.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and H.M. Sampoerna Tbk. is more actively traded (7.53M versus 71K). Which is the better fit depends on your goals.
| HMSP | OBAT | |
|---|---|---|
Market Cap | 79.68T | 167.37B |
Volume | 7.53M | 71K |
Lot | 75.28K | 710 |
Turnover | 5.2B | 17.51M |
Average Price | 690.76 | 246.63 |
Value | 5.2B | 17.51M |
Indicative Equilibrium Price | 695 | 246 |
Indicative Equilibrium Volume | 4.92K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Hanjaya Mandala Sampoerna Tbk (the Company) was established in Indonesia on October 19, 1963 based on Notarial Deed No. 69 of Anwar Mahajudin, S.H.. The Company started its commercial operation since 1913 in Surabaya, as a home industry. In 1930, this home industry was officially organized under the name of NVBM Handel Maatschapij Sampoerna.
Read more on HMSP →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →